Logo image of WAI

TOP KINGWIN LTD-A (WAI) Stock Fundamental Analysis

NASDAQ:WAI - Nasdaq - KYG8923U1031 - Common Stock - Currency: USD

1.84  -0.07 (-3.66%)

Fundamental Rating

2

Taking everything into account, WAI scores 2 out of 10 in our fundamental rating. WAI was compared to 232 industry peers in the Capital Markets industry. While WAI seems to be doing ok healthwise, there are quite some concerns on its profitability. WAI does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

WAI had negative earnings in the past year.
WAI had a negative operating cash flow in the past year.
In multiple years WAI reported negative net income over the last 5 years.
In multiple years WAI reported negative operating cash flow during the last 5 years.
WAI Yearly Net Income VS EBIT VS OCF VS FCFWAI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 0 -10M -20M -30M

1.2 Ratios

WAI has a worse Return On Assets (-6.13%) than 82.76% of its industry peers.
With a Return On Equity value of -7.14%, WAI is not doing good in the industry: 78.45% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -6.13%
ROE -7.14%
ROIC N/A
ROA(3y)-20.31%
ROA(5y)-0.54%
ROE(3y)-33.69%
ROE(5y)11.43%
ROIC(3y)N/A
ROIC(5y)N/A
WAI Yearly ROA, ROE, ROICWAI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 0 20 -20 40 -40 60 80

1.3 Margins

WAI has a better Gross Margin (65.89%) than 71.98% of its industry peers.
In the last couple of years the Gross Margin of WAI has declined.
The Profit Margin and Operating Margin are not available for WAI so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 65.89%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-23.26%
GM growth 5YN/A
WAI Yearly Profit, Operating, Gross MarginsWAI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 0 -100 -200

More info and screens

5

2. Health

2.1 Basic Checks

Compared to 1 year ago, WAI has more shares outstanding
The debt/assets ratio for WAI is higher compared to a year ago.
WAI Yearly Shares OutstandingWAI Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 50M 100M 150M
WAI Yearly Total Debt VS Total AssetsWAI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 10M 20M 30M 40M

2.2 Solvency

WAI has an Altman-Z score of 2.02. This is not the best score and indicates that WAI is in the grey zone with still only limited risk for bankruptcy at the moment.
WAI has a better Altman-Z score (2.02) than 70.26% of its industry peers.
WAI has a Debt/Equity ratio of 0.06. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of WAI (0.06) is better than 81.90% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.06
Debt/FCF N/A
Altman-Z 2.02
ROIC/WACCN/A
WACCN/A
WAI Yearly LT Debt VS Equity VS FCFWAI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 0 20M -20M

2.3 Liquidity

WAI has a Current Ratio of 7.29. This indicates that WAI is financially healthy and has no problem in meeting its short term obligations.
With an excellent Current ratio value of 7.29, WAI belongs to the best of the industry, outperforming 90.09% of the companies in the same industry.
A Quick Ratio of 7.29 indicates that WAI has no problem at all paying its short term obligations.
The Quick ratio of WAI (7.29) is better than 90.09% of its industry peers.
Industry RankSector Rank
Current Ratio 7.29
Quick Ratio 7.29
WAI Yearly Current Assets VS Current LiabilitesWAI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 10M 20M 30M 40M

More info and screens

0

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 39.40% over the past year.
Looking at the last year, WAI shows a very negative growth in Revenue. The Revenue has decreased by -31.16% in the last year.
The Revenue for WAI have been decreasing by -15.85% on average. This is quite bad
EPS 1Y (TTM)39.4%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%44.61%
Revenue 1Y (TTM)-31.16%
Revenue growth 3Y-15.85%
Revenue growth 5YN/A
Sales Q2Q%722.88%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
WAI Yearly Revenue VS EstimatesWAI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2M 4M 6M

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for WAI. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
WAI Price Earnings VS Forward Price EarningsWAI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
WAI Per share dataWAI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 -4

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for WAI!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

TOP KINGWIN LTD-A

NASDAQ:WAI (6/13/2025, 8:00:02 PM)

1.84

-0.07 (-3.66%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners0.17%
Inst Owner ChangeN/A
Ins Owners0.05%
Ins Owner ChangeN/A
Market Cap13.58M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short Ratio0.29
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 2.49
P/FCF N/A
P/OCF N/A
P/B 0.38
P/tB 0.38
EV/EBITDA N/A
EPS(TTM)-2.16
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-5.34
FCFYN/A
OCF(TTM)-5.34
OCFYN/A
SpS0.74
BVpS4.84
TBVpS4.83
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -6.13%
ROE -7.14%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 65.89%
FCFM N/A
ROA(3y)-20.31%
ROA(5y)-0.54%
ROE(3y)-33.69%
ROE(5y)11.43%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-23.26%
GM growth 5YN/A
F-Score4
Asset Turnover0.13
Health
Industry RankSector Rank
Debt/Equity 0.06
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 60.4%
Cap/Sales 0.99%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 7.29
Quick Ratio 7.29
Altman-Z 2.02
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)82.9%
Cap/Depr(5y)408.17%
Cap/Sales(3y)1.53%
Cap/Sales(5y)3.34%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)39.4%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%44.61%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-31.16%
Revenue growth 3Y-15.85%
Revenue growth 5YN/A
Sales Q2Q%722.88%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-186.66%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-2169.52%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-2291.96%
OCF growth 3YN/A
OCF growth 5YN/A